![](/images/general/no_picture/200_user.png)
Hoa T Le
Examiner (ID: 13075, Phone: (571)272-1511 , Office: P/1788 )
Most Active Art Unit | 1788 |
Art Unit(s) | 1794, 1787, 1316, 2899, 1773, 1788, 1509, 1709 |
Total Applications | 2557 |
Issued Applications | 1900 |
Pending Applications | 185 |
Abandoned Applications | 471 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17052179
[patent_doc_number] => 20210261613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
[patent_app_type] => utility
[patent_app_number] => 17/064937
[patent_app_country] => US
[patent_app_date] => 2020-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17064937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/064937 | AROMATIC-CATIONIC PEPTIDES AND USES OF SAME | Oct 6, 2020 | Abandoned |
Array
(
[id] => 18368141
[patent_doc_number] => 11648289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Antibacterial method
[patent_app_type] => utility
[patent_app_number] => 17/060648
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16855
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060648 | Antibacterial method | Sep 30, 2020 | Issued |
Array
(
[id] => 16598057
[patent_doc_number] => 20210024588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => ANTIBACTERIAL METHOD
[patent_app_type] => utility
[patent_app_number] => 17/060592
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060592 | ANTIBACTERIAL METHOD | Sep 30, 2020 | Abandoned |
Array
(
[id] => 16870090
[patent_doc_number] => 20210163557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY
[patent_app_type] => utility
[patent_app_number] => 17/018450
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018450
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018450 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY | Sep 10, 2020 | Abandoned |
Array
(
[id] => 16946724
[patent_doc_number] => 20210205415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/940610
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96517
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940610 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | Jul 27, 2020 | Abandoned |
Array
(
[id] => 16435761
[patent_doc_number] => 20200353086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => CONTROLLED-RELEASE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/939778
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939778 | CONTROLLED-RELEASE FORMULATIONS | Jul 26, 2020 | Abandoned |
Array
(
[id] => 18368174
[patent_doc_number] => 11648323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Heteromultivalent particle compositions
[patent_app_type] => utility
[patent_app_number] => 16/933434
[patent_app_country] => US
[patent_app_date] => 2020-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 33
[patent_no_of_words] => 21321
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933434
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/933434 | Heteromultivalent particle compositions | Jul 19, 2020 | Issued |
Array
(
[id] => 16389674
[patent_doc_number] => 20200330615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => NONINVASIVE IMAGING OF FOCAL ATHEROSCLEROTIC LESIONS USING FLUORESCENCE MOLECULAR TOMOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 16/919540
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919540 | NONINVASIVE IMAGING OF FOCAL ATHEROSCLEROTIC LESIONS USING FLUORESCENCE MOLECULAR TOMOGRAPHY | Jul 1, 2020 | Abandoned |
Array
(
[id] => 16376358
[patent_doc_number] => 20200325200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15)
[patent_app_type] => utility
[patent_app_number] => 16/918088
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16918088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/918088 | METHOD OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) | Jun 30, 2020 | Abandoned |
Array
(
[id] => 16343895
[patent_doc_number] => 20200308545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS
[patent_app_type] => utility
[patent_app_number] => 16/901956
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16901956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/901956 | CONDITIONALLY IMMORTALIZED LONG-TERM STEM CELLS AND METHODS OF MAKING AND USING SUCH CELLS | Jun 14, 2020 | Abandoned |
Array
(
[id] => 16807850
[patent_doc_number] => 20210130403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => INHIBITORS OF METASTASIS
[patent_app_type] => utility
[patent_app_number] => 16/900130
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/900130 | Inhibitors of metastasis | Jun 11, 2020 | Issued |
Array
(
[id] => 18779143
[patent_doc_number] => 11820837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Modified peptides and associated methods of use
[patent_app_type] => utility
[patent_app_number] => 16/892013
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 22342
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16892013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/892013 | Modified peptides and associated methods of use | Jun 2, 2020 | Issued |
Array
(
[id] => 17843777
[patent_doc_number] => 11433119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Methods of treating inflammatory skin disorders
[patent_app_type] => utility
[patent_app_number] => 16/888711
[patent_app_country] => US
[patent_app_date] => 2020-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 11941
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888711
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888711 | Methods of treating inflammatory skin disorders | May 29, 2020 | Issued |
Array
(
[id] => 16397310
[patent_doc_number] => 20200338168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/888708
[patent_app_country] => US
[patent_app_date] => 2020-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888708 | Methods of treating inflammatory skin disorders | May 29, 2020 | Issued |
Array
(
[id] => 16482319
[patent_doc_number] => 20200375919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => BONE GRAFT MATERIAL WITH 4-HEXYLRESORCINOL THAT AFFECTS BONE FORMATION
[patent_app_type] => utility
[patent_app_number] => 16/884300
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884300
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884300 | BONE GRAFT MATERIAL WITH 4-HEXYLRESORCINOL THAT AFFECTS BONE FORMATION | May 26, 2020 | Abandoned |
Array
(
[id] => 18050710
[patent_doc_number] => 11524077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-13
[patent_title] => Orally active, cell-penetrating homing peptide and methods using same
[patent_app_type] => utility
[patent_app_number] => 16/878325
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 6651
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878325
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878325 | Orally active, cell-penetrating homing peptide and methods using same | May 18, 2020 | Issued |
Array
(
[id] => 16252217
[patent_doc_number] => 20200261591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => METHODS FOR PROMOTING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/862570
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862570 | METHODS FOR PROMOTING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS | Apr 29, 2020 | Abandoned |
Array
(
[id] => 17170355
[patent_doc_number] => 20210324025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CORNEAL ENDOTHELIUM
[patent_app_type] => utility
[patent_app_number] => 16/863435
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863435 | COMPOSITIONS AND METHODS FOR TREATING CORNEAL ENDOTHELIUM | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16236650
[patent_doc_number] => 20200253884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => NANOBIOLOGIC COMPOSITIONS FOR PROMOTING TRAINED IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 16/862564
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 216
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862564 | NANOBIOLOGIC COMPOSITIONS FOR PROMOTING TRAINED IMMUNITY | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16325975
[patent_doc_number] => 20200296940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => PEARL CULTURE MATERIAL AND COATING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/862590
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8104
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/862590 | PEARL CULTURE MATERIAL AND COATING COMPOSITION | Apr 29, 2020 | Abandoned |